These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2876513)

  • 21. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer].
    Di Mario F; Gottardello L; Burra P; Salvagnini M; Dalrì L; Leandro G; Contento F; Torri A; Naccarato R
    G Clin Med; 1990 Apr; 71(4):259-62, 265-6. PubMed ID: 1973392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the treatment of digestive diseases.
    Sun HS
    J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
    Glubochenko VG; Shcherbak VV
    Vrach Delo; 1985 Feb; (2):13-5. PubMed ID: 2859701
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modified H2 receptor blockers in ulcus therapy].
    Domschke S; Domschke W
    Dtsch Med Wochenschr; 1982 Dec; 107(48):1827-30. PubMed ID: 6128214
    [No Abstract]   [Full Text] [Related]  

  • 26. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1992 Feb; 6(1):3-29. PubMed ID: 1347467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duodenal ulcer. Who should have long-term maintenance therapy?
    Zuckerman G
    Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
    Inoue M
    Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists.
    Boero M; Pera A; Andriulli A; Ponti V; Canepa G; Palmas F; Duglio A; Molinaro GC; Toselli M; Riccardino N
    Digestion; 1983; 28(3):158-63. PubMed ID: 6141973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical treatment of peptic ulcer disease.
    Rubin W
    Med Clin North Am; 1991 Jul; 75(4):981-98. PubMed ID: 1677060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cimetidine in the treatment of peptic ulcer].
    Pera A; Lombardo L; Crivelli O; Verme G
    Minerva Med; 1977 Oct; 68(47):3277-82. PubMed ID: 335279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist.
    Mohammed R; Mitchell KG; Mackay C
    Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs for peptic ulcer.
    Clark CG; Wyllie JH
    World J Surg; 1977 Jan; 1(1):3-7. PubMed ID: 17229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists.
    Brooks WS
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():47-52. PubMed ID: 1349553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H2-receptor antagonists and peptic ulcer disease.
    Thompson MH
    South Med J; 1978 Jul; 71(7):753. PubMed ID: 26979
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of H2-receptor antagonists on the complications, morbidity and mortality of peptic ulcer disease.
    Isenberg JI
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():447S-454S. PubMed ID: 2908766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.